标题
Hepatitis D virus: Improving virological knowledge to develop new treatments
作者
关键词
-
出版物
ANTIVIRAL RESEARCH
Volume 209, Issue -, Pages 105461
出版商
Elsevier BV
发表日期
2022-11-14
DOI
10.1016/j.antiviral.2022.105461
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method
- (2022) Eloi R. Verrier et al. ANTIVIRAL RESEARCH
- Petabase-scale sequence alignment catalyses viral discovery
- (2022) Robert C. Edgar et al. NATURE
- Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—Results of A “real world” Study
- (2022) Mathias Jachs et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus
- (2022) Carla Usai et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study
- (2022) H. Wedemeyer et al. DIGESTIVE AND LIVER DISEASE
- Hepatitis delta treatment with bulevirtide in real life: a case report
- (2022) Marc-Antoine GIORDAN et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosis
- (2022) Caroline Schwarz et al. JOURNAL OF HEPATOLOGY
- Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection
- (2022) Toni Herta et al. Pathogens
- Bulevirtide monotherapy for 48 Weeks in hdv patients with compensated cirrhosis and clinically significant portal hypertension
- (2022) Elisabetta Degasperi et al. JOURNAL OF HEPATOLOGY
- Diversification of mammalian deltaviruses by host shifting
- (2021) Laura M. Bergner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of novel avian and mammalian deltaviruses provides new insights into deltavirus evolution
- (2021) Masashi Iwamoto et al. Virus Evolution
- Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real life
- (2021) Tarik Asselah et al. LIVER INTERNATIONAL
- Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
- (2021) Tyng-Yuan Jang et al. Scientific Reports
- New therapies for hepatitis delta virus infection
- (2021) Dimitri Loureiro et al. LIVER INTERNATIONAL
- HDV-Like Viruses
- (2021) Jimena Pérez-Vargas et al. Viruses-Basel
- HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection
- (2021) Imme Roggenbach et al. Viruses-Basel
- Safety and effectiveness of up to 3 years’ bulevirtide monotherapy in patients with HDV-related cirrhosis
- (2021) Alessandro Loglio et al. JOURNAL OF HEPATOLOGY
- Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis
- (2021) Lin-Yuan Chen et al. Gut Pathogens
- Hepatitis B Surface Antigen Seroclearance: Immune Mechanisms, Clinical Impact, Importance for Drug Development
- (2020) Issam Tout et al. JOURNAL OF HEPATOLOGY
- The global prevalence of hepatitis D virus infection: systematic review and meta-analysis
- (2020) Alexander J. Stockdale et al. JOURNAL OF HEPATOLOGY
- Snake Deltavirus Utilizes Envelope Proteins of Different Viruses To Generate Infectious Particles
- (2020) Leonora Szirovicza et al. mBio
- Preliminary evidence for hdv exposure in apparently non‐HBV‐infected patients
- (2020) Isabelle Chemin et al. HEPATOLOGY
- Mammalian deltavirus without hepadnavirus coinfection in the neotropical rodentProechimys semispinosus
- (2020) Sofia Paraskevopoulou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hepatitis B Virus Entry into Cells
- (2020) Charline Herrscher et al. Cells
- 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales
- (2020) Jens H. Kuhn et al. ARCHIVES OF VIROLOGY
- Bulevirtide: First Approval
- (2020) Connie Kang et al. DRUGS
- A Phase 2 Study of Peginterferon Lambda, Lonafarnib and Ritonavir for 24 Weeks: End-of-Treatment Results from the LIFT HDV Study
- (2020) Christopher Koh et al. JOURNAL OF HEPATOLOGY
- No Evidence of Hepatitis C Virus (HCV)–Assisted Hepatitis D Virus Propagation in a Large Cohort of HCV-Positive Blood Donors
- (2020) Pierre Cappy et al. JOURNAL OF INFECTIOUS DISEASES
- Hepatitis delta virus propagation enabled by hepatitis C virus—Scientifically intriguing, but is it relevant to clinical practice?
- (2020) Lisa Sophie Pflüger et al. JOURNAL OF VIRAL HEPATITIS
- Murine hepatocytes do not support persistence of Hepatitis D virus mono‐infection in vivo
- (2020) Katja Giersch et al. LIVER INTERNATIONAL
- Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial
- (2019) Heiner Wedemeyer et al. LANCET INFECTIOUS DISEASES
- Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells
- (2019) Matthieu Blanchet et al. ANTIVIRAL RESEARCH
- PS-052-End of study results from LIMT HDV study: 36% durable virologic response at 24 weeks post-treatment with pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection
- (2019) Ohad Etzion et al. JOURNAL OF HEPATOLOGY
- GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection
- (2019) Heiner Wedemeyer et al. JOURNAL OF HEPATOLOGY
- Identification of a Novel Deltavirus in Boa Constrictors
- (2019) Udo Hetzel et al. mBio
- Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo
- (2019) Jimena Perez-Vargas et al. Nature Communications
- Analysis of host responses to hepatitis B and delta viral infections in a micro-scalable hepatic co-culture system
- (2019) Benjamin Y. Winer et al. HEPATOLOGY
- Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference
- (2019) Markus Cornberg et al. JOURNAL OF HEPATOLOGY
- Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure
- (2019) Tarik Asselah et al. Lancet Gastroenterology & Hepatology
- Optimizing lonafarnib treatment for the management of chronic delta hepatitis: The LOWR HDV-1 study
- (2018) Cihan Yurdaydin et al. HEPATOLOGY
- Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks
- (2018) Jonathan Quinet et al. HEPATOLOGY
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Updated follow-up analysis in the REP 401 protocol: Treatment HBeAg negative chronic hepatitis B infection with REP 2139 or REP 2165, tenofovir disoproxil fumarate and pegylated interferon alfa-2a
- (2018) A. Vaillant et al. JOURNAL OF HEPATOLOGY
- Final results of a multicenter, open-label phase 2b clinical trial to assess safety and efficacy of Myrcludex B in combination with Tenofovir in patients with chronic HBV/HDV co-infection
- (2018) H. Wedemeyer et al. JOURNAL OF HEPATOLOGY
- Strong intrahepatic decline of hepatitis D virus RNA and antigen after 24 weeks of treatment with Myrcludex B in combinationwith Tenofovir in chronic HBV/HDV infected patients: Interim results from a multicenter, open-label phase 2b clinical trial
- (2018) L. Allweiss et al. JOURNAL OF HEPATOLOGY
- Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes
- (2018) Zhenfeng Zhang et al. JOURNAL OF HEPATOLOGY
- Towards HBV curative therapies
- (2018) Raymond F. Schinazi et al. LIVER INTERNATIONAL
- Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?
- (2018) Tarik Asselah et al. LIVER INTERNATIONAL
- REP 2139: antiviral mechanisms and applications in achieving functional control of HBV and HDV infection
- (2018) Andrew Vaillant ACS Infectious Diseases
- Treating Chronic Hepatitis Delta: The Need for Surrogate Markers of Treatment Efficacy
- (2018) Cihan Yurdaydin et al. JOURNAL OF HEPATOLOGY
- A Divergent Hepatitis D-Like Agent in Birds
- (2018) Michelle Wille et al. Viruses-Basel
- Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo
- (2017) Katja Giersch et al. GUT
- A phase 2 study exploring once daily dosing of ritonavir boosted lonafarnib for the treatment of chronic delta hepatitis – end of study results from the LOWR HDV-3 study
- (2017) C. Koh et al. JOURNAL OF HEPATOLOGY
- A phase 2 dose-escalation study of lonafarnib plus ritonavir in patients with chronic hepatitis D: final results from the Lonafarnib with ritonavir in HDV-4 (LOWR HDV-4) study
- (2017) H. Wedemeyer et al. JOURNAL OF HEPATOLOGY
- A phase 2 dose-optimization study of lonafarnib with ritonavir for the treatment of chronic delta hepatitis—end of treatment results from the LOWR HDV-2 study
- (2017) C. Yurdaydin et al. JOURNAL OF HEPATOLOGY
- Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application
- (2017) Jianming Hu et al. Viruses-Basel
- Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
- (2017) Katja Giersch et al. Scientific Reports
- HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response
- (2016) G. A. Niro et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes
- (2016) Dulce Alfaiate et al. ANTIVIRAL RESEARCH
- IFN-lambda therapy: current status and future perspectives
- (2016) Ahmed Lasfar et al. DRUG DISCOVERY TODAY
- Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
- (2016) Henry L.Y. Chan et al. JOURNAL OF HEPATOLOGY
- First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
- (2016) Antje Blank et al. JOURNAL OF HEPATOLOGY
- Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
- (2016) Pavel Bogomolov et al. JOURNAL OF HEPATOLOGY
- The hepatitis delta virus: Replication and pathogenesis
- (2016) Camille Sureau et al. JOURNAL OF HEPATOLOGY
- Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
- (2016) Florian A. Lempp et al. Nature Reviews Gastroenterology & Hepatology
- A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3
- (2016) Graham R. Foster et al. SpringerPlus
- Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
- (2016) Mamun Al-Mahtab et al. PLoS One
- Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome
- (2015) Onur Keskin et al. Clinical Gastroenterology and Hepatology
- Pegylated interferon therapy of chronic hepatitis D: In need of revision
- (2015) Mario Rizzetto et al. HEPATOLOGY
- Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na+-taurocholate cotransporting polypeptide knockout mice
- (2015) Davor Slijepcevic et al. HEPATOLOGY
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
- (2015) Christopher Koh et al. LANCET INFECTIOUS DISEASES
- Hepatitis D Virus Replication
- (2015) John M. Taylor Cold Spring Harbor Perspectives in Medicine
- Long-term therapy of chronic delta hepatitis with peginterferon alfa
- (2014) T. Heller et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
- (2014) Stephan Urban et al. GASTROENTEROLOGY
- Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta
- (2014) Benjamin Heidrich et al. HEPATOLOGY
- Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling
- (2014) Jeremie Guedj et al. HEPATOLOGY
- Envelope Proteins Derived from Naturally Integrated Hepatitis B Virus DNA Support Assembly and Release of Infectious Hepatitis Delta Virus Particles
- (2014) N. Freitas et al. JOURNAL OF VIROLOGY
- Hepatitis Delta Antigen Requires a Flexible Quasi-Double-Stranded RNA Structure To Bind and Condense Hepatitis Delta Virus RNA in a Ribonucleoprotein Complex
- (2014) B. L. Griffin et al. JOURNAL OF VIROLOGY
- Hepatitis D Virus Coinfection and Superinfection
- (2014) F. Negro Cold Spring Harbor Perspectives in Medicine
- Nucleic Acid Polymers Prevent the Establishment of Duck Hepatitis B Virus InfectionIn Vivo
- (2013) Faseeha Noordeen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nucleic Acid Polymers Inhibit Duck Hepatitis B Virus InfectionIn Vitro
- (2013) Faseeha Noordeen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
- (2013) Yi Ni et al. GASTROENTEROLOGY
- Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts
- (2013) Alexa Schieck et al. HEPATOLOGY
- Targeted Induction of Interferon-λ in Humanized Chimeric Mouse Liver Abrogates Hepatotropic Virus Infection
- (2013) Shin-ichiro Nakagawa et al. PLoS One
- The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
- (2012) Tassilo Volz et al. JOURNAL OF HEPATOLOGY
- Large hepatitis delta antigen activates STAT-3 and NF-κB via oxidative stress
- (2012) V. Williams et al. JOURNAL OF VIRAL HEPATITIS
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
- Treatment Options for Hepatitis Delta Virus Infection
- (2012) Benjamin Heidrich et al. Current Infectious Disease Reports
- Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
- (2011) Heiner Wedemeyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon Impedes an Early Step of Hepatitis Delta Virus Infection
- (2011) Ziying Han et al. PLoS One
- Phase I and pharmacokinetic study of lonafarnib, SCH 66336, using a 2-week on, 2-week off schedule in patients with advanced solid tumors
- (2010) Carlos Castaneda et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Natural history and treatment of chronic delta hepatitis
- (2010) C. Yurdaydın et al. JOURNAL OF VIRAL HEPATITIS
- Solid-Phase Synthesis of the Lipopeptide Myr-HBVpreS/2-78, a Hepatitis B Virus Entry Inhibitor
- (2010) Alexa Schieck et al. MOLECULES
- Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead
- (2010) Heiner Wedemeyer et al. Nature Reviews Gastroenterology & Hepatology
- Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
- (2010) Jean-Pierre Vartanian et al. PLoS Pathogens
- A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma
- (2009) Raffaella Romeo et al. GASTROENTEROLOGY
- Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene
- (2009) V. Williams et al. JOURNAL OF GENERAL VIROLOGY
- Modification of Small Hepatitis Delta Virus Antigen by SUMO Protein
- (2009) C.-H. Tseng et al. JOURNAL OF VIROLOGY
- Hepatitis Delta Antigen Requires a Minimum Length of the Hepatitis Delta Virus Unbranched Rod RNA Structure for Binding
- (2009) D. A. Defenbaugh et al. JOURNAL OF VIROLOGY
- The hepatitis delta virus RNA genome interacts with the human RNA polymerases I and III
- (2009) Valerie S. Greco-Stewart et al. VIROLOGY
- Hepatitis delta virus inhibits alpha interferon signaling
- (2008) Paolo Pugnale et al. HEPATOLOGY
- Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon
- (2008) C. Yurdaydın et al. JOURNAL OF VIRAL HEPATITIS
- Transcription of Subgenomic mRNA of Hepatitis Delta Virus Requires a Modified Hepatitis Delta Antigen That Is Distinct from Antigenomic RNA Synthesis
- (2008) C.-H. Tseng et al. JOURNAL OF VIROLOGY
- Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein
- (2008) Joerg Petersen et al. NATURE BIOTECHNOLOGY
- IFN-Lambda (IFN-λ) Is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo
- (2008) Caroline Sommereyns et al. PLoS Pathogens
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now